Hospital Universitario San Carlos

Madrid 28040

2 studies enrolling now · 10 studies all time

What they study most

Bladder Cancer, Breast Cancer, Endometrial Cancer, Fallopian Tube Cancer, Leiomyosarcoma, Liposarcoma, Low-grade Serous Ovarian Cancer, Metastatic Cancer, Ovarian Cancer, Peritoneal Cancer, Recurrent Endometrial Cancer, Recurrent Fallopian Tube Cancer

Studies at this site

• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers — Recruiting now
• Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma — Recruiting now
• Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies — Completed
• Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) — Completed
• Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients — Completed
• Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer — Completed
• Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma — Stopped early
• Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer — Completed